Pediatric patients aged 12 years and older treated with Wegovy had greater incidences of cholelithiasis, cholecystitis, hypotension, rash, and urticaria compared to adults treated with Wegovy 1 There are insufficient data in pediatric patients with type 2 diabetes treated with Wegovy for obesity to determine if there is an increased risk of hypoglycemia with Wegovy treatment similar to that reported in adults
Modulating macrophage polarization, inhibiting pro-inflammatory signaling pathways, and promoting tissue repair mechanisms are potential approaches for attenuating inflammation, reducing tissue damage, and improving lung function in individuals with COPD
suis and H
So many people have chosen semaglutide as their go-to treatment that pharmacies have experienced shortages
Close monitoring is essential for depression and suicidal ideation during therapy
IL-17 induces cellular stress microenvironment of melanocytes to promote autophagic cell apoptosis in vitiligo